Evaluating the Impact of Introducing Basaglar, a Long-Acting Analog Insulin, on Clinical and Quality of Life Outcomes in Youth with Diabetes in Bangladesh

In partnership with the Life for a Child Program and Diabetic Association of Bangladesh, we are conducting a study evaluating the introduction of Basaglar, a long-acting analog insulin. This research delves into the clinical and quality of life outcomes in youth with diabetes in Bangladesh. By assessing the impact of this advanced insulin type, we strive to enhance both the medical outcomes and the overall quality of life for our young patients.